Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 12, 2016 4:06 AM ET


Company Overview of Reckitt Benckiser Pharmaceuticals, Inc.

Company Overview

Reckitt Benckiser Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company offers opioid medication under the brand name Suboxone and sublingual tablets under the brand name Subutex. Reckitt Benckiser Pharmaceuticals, Inc. was formerly known as Reckitt & Colman Pharmaceuticals, Inc. The company was incorporated in 1997 and is based in Richmond, Virginia. Reckitt Benckiser Pharmaceuticals, Inc. operates as a subsidiary of Reckitt Benckiser Group plc.

The Fairfax Building

10710 Midlothian Turnpike

Suite 430

Richmond, VA 23235

United States

Founded in 1997





Key Executives for Reckitt Benckiser Pharmaceuticals, Inc.

Chief Financial Officer
Age: 54
Compensation as of Fiscal Year 2015.

Reckitt Benckiser Pharmaceuticals, Inc. Key Developments

Reckitt Benckiser Pharmaceuticals, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 10:40 AM

Reckitt Benckiser Pharmaceuticals, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 10:40 AM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom.

Reckitt Benckiser Pharmaceuticals Inc. Appoints Cary J. Claiborne as Chief Financial Officer, effective November 10, 2014

Reckitt Benckiser Pharmaceuticals Inc. announced appointment of Cary J. Claiborne as Chief Financial Officer. Cary will lead the company's global financial and information technology operations, reporting to Chief Executive Officer Shaun Thaxter effective November 10, 2014. Prior to his appointment at Reckitt Benckiser Pharmaceuticals, Cary served as Chief Financial Officer of Sucampo Pharmaceuticals Inc.

AntiOp, Inc. Partners with Reckitt Benckiser Pharmaceuticals, Inc. to Develop Nasally Administered Treatment for Opioid Overdose

AntiOp, Inc. has signed an agreement with Reckitt Benckiser Pharmaceuticals, Inc. to accelerate production and worldwide marketing of intranasal naloxone, a drug designed to treat opioid overdose. This partnership leverages the combined resources and strengths. The Centers for Disease Control's recent statistics indicate a steadily increasing number of deaths due to opioid overdose. The number has tripled since 1990, with a more recent statistic citing 16,500 deaths in the U.S. from prescription opioids alone, principally painkillers such as hydrocodone, methadone, oxycodone and oxymorphone. Related statistics show approximately 800,000 ambulance runs in the U.S. each year related to suspected opioid overdoses involving both prescription opioids and heroin.

Similar Private Companies By Industry

Company Name Region
Matrivax Research & Development Corp. United States
IVAX Pharmaceuticals, Inc. United States
Bioponic Phytoceuticals, Inc. United States
Novartis Finance Corporation United States
Silarx Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Reckitt Benckiser Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at